Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
AMSG's Cash to Debt is ranked higher than
55% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 0.21 vs. AMSG: 0.09 )
AMSG' s 10-Year Cash to Debt Range
Min: 0.07   Max: 0.71
Current: 0.09

0.07
0.71
Equity to Asset 0.30
AMSG's Equity to Asset is ranked higher than
58% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. AMSG: 0.30 )
AMSG' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.77
Current: 0.3

0.3
0.77
F-Score: 5
Z-Score: 1.18
M-Score: -2.16
WACC vs ROIC
8.61%
14.80%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.28
AMSG's Operating margin (%) is ranked higher than
96% of the 346 Companies
in the Global Medical Care industry.

( Industry Median: 8.96 vs. AMSG: 24.28 )
AMSG' s 10-Year Operating margin (%) Range
Min: 24.31   Max: 63.3
Current: 24.28

24.31
63.3
Net-margin (%) 3.30
AMSG's Net-margin (%) is ranked higher than
69% of the 346 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. AMSG: 3.30 )
AMSG' s 10-Year Net-margin (%) Range
Min: 0.17   Max: 12
Current: 3.3

0.17
12
ROE (%) 4.72
AMSG's ROE (%) is ranked higher than
63% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 10.33 vs. AMSG: 4.72 )
AMSG' s 10-Year ROE (%) Range
Min: 1.6   Max: 16.3
Current: 4.72

1.6
16.3
ROA (%) 1.53
AMSG's ROA (%) is ranked higher than
63% of the 351 Companies
in the Global Medical Care industry.

( Industry Median: 4.09 vs. AMSG: 1.53 )
AMSG' s 10-Year ROA (%) Range
Min: 0.92   Max: 10.16
Current: 1.53

0.92
10.16
ROC (Joel Greenblatt) (%) 137.90
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 17.65 vs. AMSG: 137.90 )
AMSG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 83.63   Max: 204.41
Current: 137.9

83.63
204.41
Revenue Growth (3Y)(%) 18.00
AMSG's Revenue Growth (3Y)(%) is ranked higher than
92% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. AMSG: 18.00 )
AMSG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 9.9   Max: 19.4
Current: 18

9.9
19.4
EBITDA Growth (3Y)(%) 10.50
AMSG's EBITDA Growth (3Y)(%) is ranked higher than
81% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. AMSG: 10.50 )
AMSG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9   Max: 40.6
Current: 10.5

-9
40.6
EPS Growth (3Y)(%) -7.40
AMSG's EPS Growth (3Y)(%) is ranked higher than
59% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. AMSG: -7.40 )
AMSG' s 10-Year EPS Growth (3Y)(%) Range
Min: -7.4   Max: 135.1
Current: -7.4

-7.4
135.1
» AMSG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

AMSG Guru Trades in Q1 2014

Joel Greenblatt 123,375 sh (New)
Jim Simons 237,969 sh (+58.12%)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
» More
Q2 2014

AMSG Guru Trades in Q2 2014

Paul Tudor Jones 131,573 sh (New)
Louis Moore Bacon 110,000 sh (New)
Joel Greenblatt 149,988 sh (+21.57%)
Jim Simons 245,469 sh (+3.15%)
» More
Q3 2014

AMSG Guru Trades in Q3 2014

Joel Greenblatt 586,771 sh (+291.21%)
Louis Moore Bacon Sold Out
Jim Simons 19,469 sh (-92.07%)
Paul Tudor Jones 7,700 sh (-94.15%)
» More
Q4 2014

AMSG Guru Trades in Q4 2014

Steven Cohen 215,800 sh (New)
Jim Simons 160,369 sh (+723.71%)
Paul Tudor Jones 11,500 sh (+49.35%)
Joel Greenblatt Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Amsurg Corp

SymbolPriceYieldDescription
AMSGP128.613.05

Ratios

vs
industry
vs
history
P/E(ttm) 46.20
AMSG's P/E(ttm) is ranked higher than
70% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 56.80 vs. AMSG: 46.20 )
AMSG' s 10-Year P/E(ttm) Range
Min: 9.07   Max: 47.2
Current: 46.2

9.07
47.2
Forward P/E 16.84
AMSG's Forward P/E is ranked higher than
88% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 16.84 )
N/A
PE(NRI) 44.70
AMSG's PE(NRI) is ranked higher than
76% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 54.10 vs. AMSG: 44.70 )
AMSG' s 10-Year PE(NRI) Range
Min: 8.55   Max: 44.68
Current: 44.7

8.55
44.68
P/B 2.10
AMSG's P/B is ranked higher than
80% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 3.60 vs. AMSG: 2.10 )
AMSG' s 10-Year P/B Range
Min: 0.93   Max: 3.4
Current: 2.1

0.93
3.4
P/S 1.58
AMSG's P/S is ranked higher than
66% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 1.89 vs. AMSG: 1.58 )
AMSG' s 10-Year P/S Range
Min: 0.7   Max: 2.69
Current: 1.58

0.7
2.69
PFCF 7.20
AMSG's PFCF is ranked higher than
96% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 116.67 vs. AMSG: 7.20 )
AMSG' s 10-Year PFCF Range
Min: 1.92   Max: 56.85
Current: 7.2

1.92
56.85
POCF 6.26
AMSG's POCF is ranked higher than
93% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. AMSG: 6.26 )
AMSG' s 10-Year POCF Range
Min: 1.75   Max: 16.23
Current: 6.26

1.75
16.23
EV-to-EBIT 14.27
AMSG's EV-to-EBIT is ranked higher than
87% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 30.31 vs. AMSG: 14.27 )
AMSG' s 10-Year EV-to-EBIT Range
Min: 3   Max: 14.6
Current: 14.27

3
14.6
PEG 4.91
AMSG's PEG is ranked higher than
89% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 4.91 )
AMSG' s 10-Year PEG Range
Min: 0.3   Max: 87.64
Current: 4.91

0.3
87.64
Shiller P/E 35.30
AMSG's Shiller P/E is ranked higher than
82% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 35.30 )
AMSG' s 10-Year Shiller P/E Range
Min: 9.92   Max: 41.08
Current: 35.3

9.92
41.08
Current Ratio 2.05
AMSG's Current Ratio is ranked higher than
86% of the 333 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. AMSG: 2.05 )
AMSG' s 10-Year Current Ratio Range
Min: 2.05   Max: 4.31
Current: 2.05

2.05
4.31
Quick Ratio 1.98
AMSG's Quick Ratio is ranked higher than
87% of the 333 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. AMSG: 1.98 )
AMSG' s 10-Year Quick Ratio Range
Min: 1.98   Max: 4.04
Current: 1.98

1.98
4.04
Days Inventory 41.86
AMSG's Days Inventory is ranked higher than
72% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 42.45 vs. AMSG: 41.86 )
AMSG' s 10-Year Days Inventory Range
Min: 11   Max: 46.57
Current: 41.86

11
46.57
Days Sales Outstanding 52.30
AMSG's Days Sales Outstanding is ranked higher than
71% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 54.36 vs. AMSG: 52.30 )
AMSG' s 10-Year Days Sales Outstanding Range
Min: 35.64   Max: 62.96
Current: 52.3

35.64
62.96

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.60
AMSG's Price/DCF (Projected) is ranked higher than
97% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 0.60 )
AMSG' s 10-Year Price/DCF (Projected) Range
Min: 0.27   Max: 2.49
Current: 0.6

0.27
2.49
Price/Median PS Value 1.20
AMSG's Price/Median PS Value is ranked higher than
71% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. AMSG: 1.20 )
AMSG' s 10-Year Price/Median PS Value Range
Min: 0.69   Max: 2.01
Current: 1.2

0.69
2.01
Price/Peter Lynch Fair Value 4.40
AMSG's Price/Peter Lynch Fair Value is ranked higher than
87% of the 404 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. AMSG: 4.40 )
AMSG' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.53   Max: 3.73
Current: 4.4

0.53
3.73
Earnings Yield (Greenblatt) 6.80
AMSG's Earnings Yield (Greenblatt) is ranked higher than
83% of the 340 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. AMSG: 6.80 )
AMSG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.8   Max: 33
Current: 6.8

6.8
33
Forward Rate of Return (Yacktman) 23.00
AMSG's Forward Rate of Return (Yacktman) is ranked higher than
91% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 11.11 vs. AMSG: 23.00 )
AMSG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.2   Max: 61
Current: 23

0.2
61

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AJH.Germany,
AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.
» More Articles for AMSG

Headlines

Articles On GuruFocus.com
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
predictable Sep 28 2011 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 13 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
View on AMSG Apr 30 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 


More From Other Websites
Medicare's (Stay) Home Savings Plan Apr 17 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2015 Results Apr 10 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for First Quarter 2015 Results Apr 10 2015
AmSurg Poised on Strong Fundamentals, Strategic Buyouts - Analyst Blog Apr 06 2015
AmSurg Buys Halifax to Boost Anesthesia Services in Florida - Analyst Blog Apr 02 2015
AmSurg’s Physician Services Division, Sheridan, Acquires Halifax Anesthesiology Associates in... Apr 01 2015
AmSurg’s Physician Services Division, Sheridan, Acquires Halifax Anesthesiology Associates in... Apr 01 2015
DVL Seigenthaler CEO Ronald Roberts on what's next for the newly combined firm (Video) Mar 12 2015
AmSurg Boosts Radiology Services with Buyout in Florida - Analyst Blog Mar 11 2015
Top-Ranked ETFs from Top-Performing Sectors - ETF News And Commentary Mar 11 2015
AmSurg’s Physician Services Division, Sheridan, Completes Acquisition of Radiology Associates of... Mar 10 2015
AmSurg’s Physician Services Division, Sheridan, Completes Acquisition of Radiology Associates of... Mar 10 2015
AMSURG CORP Financials Mar 06 2015
AmSurg Declares Quarterly Preferred Stock Dividend Mar 03 2015
AmSurg Declares Quarterly Preferred Stock Dividend Mar 03 2015
Acadia, AmSurg Lead In Outpatient Medical Group Mar 02 2015
10-K for AmSurg Corp. Mar 01 2015
AmSurg Corp. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 26 2015
AmSurg Corp. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 26 2015
AmSurg Reports Fourth-Quarter and 2014 Results Feb 26 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK